Cognitive management of cerebral palsy with unani formulation [a clinical trial]

ABSTRACT

Modem medicine is trying to introduce a number of experimental therapies for reversal of neuronal damage or enhancement of neuronal functions. One of this is Unani therapy for cognitive management. We prepared an in-house formulation called Majoon Intelligent Quotient [MIQ]. The ingredients were selected based upon an extensive literature survey about their usage in neurological conditions. Small Cerebral Palsy children aged 2-6 years were selected from UDAAN, one of India's premier center for management of small moderate to severe CP children. The overall opinion on the drug seems to show a 50% responder rate in cognitive parameters in small CP children with moderate to severe cerebral palsy. We feel that this drug will have an important role in early Interventional therapy of small CP children specially those with cognitive impairment